Literature DB >> 12511530

Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium.

Stanley F Fernandez1, Ming-He Huang, Bruce A Davidson, Paul R Knight, Joseph L Izzo.   

Abstract

Both stimulatory and suppressive responses of the sympathetic nervous system to angiotensin II (AII) have been reported in intact animals. To elucidate possible cellular mechanisms, we studied AII-induced changes in cytosolic Ca2+ ([Ca2+]i) in primary cultures of rat stellate ganglion neurons. Two different patterns of [Ca2+]i responses to AII were observed: dose-dependent increases in [Ca2+]i in cells with intrinsically low baseline [Ca2+]i (n=64) and dose-dependent suppression of [Ca2+]i in neurons with intrinsically higher baseline [Ca2+]i (n=46). Individual neurons could express both response patterns to AII. In neurons with low basal [Ca2+]i, superfusion with Ca2+ ionophore (ionomycin) increased [Ca2+]i and reversed the initial AII-induced stimulatory pattern. L-type Ca2+ channel antagonism (nifedipine) in neurons with high baseline [Ca2+]i lowered [Ca2+]i and reversed the initial AII-induced suppressive response. Both stimulatory and suppressive responses were abolished by AT1 receptor antagonism (losartan). AII-induced stimulatory responses were blocked by IP3 receptor antagonism (2-APB) and by thapsigargin. AII-induced suppression of neuronal [Ca2+]i was blunted when Na-Ca exchange was impaired. We conclude that [Ca2+]i acts as a switch for AII-mediated stimulatory and suppressive responses in individual sympathetic neurons. AT1 receptor-mediated neuronal stimulation and suppression may allow local homeostatic adaptation to meet complex systemic needs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511530     DOI: 10.1161/01.hyp.0000047513.75459.7e

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  TRPV1 (Transient Receptor Potential Vanilloid 1) Cardiac Spinal Afferents Contribute to Hypertension in Spontaneous Hypertensive Rat.

Authors:  Julia Shanks; Sharon D B de Morais; Lie Gao; Irving H Zucker; Han-Jun Wang
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

2.  Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology.

Authors:  Hirenkumar K Makadia; Warren D Anderson; Dirk Fey; Thomas Sauter; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

3.  COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin II-induced formation of reactive oxygen species and Ca(2+) influx in the subfornical organ.

Authors:  Gang Wang; Pallabi Sarkar; Jeffrey R Peterson; Josef Anrather; Joseph P Pierce; Jamie M Moore; Ji Feng; Ping Zhou; Teresa A Milner; Virginia M Pickel; Costantino Iadecola; Robin L Davisson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

4.  Nitric oxide inhibits the expression of AT1 receptors in neurons.

Authors:  Neeru M Sharma; Hong Zheng; Yi-Fan Li; Kaushik P Patel
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-04       Impact factor: 4.249

5.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

6.  Area-specific differences in transmitter release in central catecholaminergic neurons of spontaneously hypertensive rats.

Authors:  Anja G Teschemacher; Sheng Wang; Mohan K Raizada; Julian F R Paton; Sergey Kasparov
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

Review 7.  Neurocardiac regulation: from cardiac mechanisms to novel therapeutic approaches.

Authors:  E N Bardsley; D J Paterson
Journal:  J Physiol       Date:  2018-11-12       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.